Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Immunol. 2011 Jul 25;187(5):2148–2154. doi: 10.4049/jimmunol.1101180

Figure 5.

Figure 5

CLP-treated Trail−/− BALB/c mice are able to control a secondary LM-OVA infection to the same degree as sham-treated mice. Sham or CLP-treated WT, Trail−/− and Dr5−/− BALB/c mice were infected with 107 CFU attenuated LM-OVA 2 d post-surgery. A. Total CD8 T cell numbers in the spleen were determined 2 d post-surgery. *p < 0.05 (Student’s t-test). B. The bacterial titer in the spleen was then determined on d 3 post-infection. The dotted line represents the limit of detection (l.o.d.).